Susan M. Webb

TL;DR: The Sarcopenia Index (SI),-(serum creatinine value [mg/dl]/serum cystatin C value[mg/L]) × 100, has been proposed as a potential, reliable surrogate marker of low muscle mass and function in patients with active Cushing’s syndrome and may be a helpful surrogate marker to identify those CS patients who are more likely to show low Muscle mass and strenght after remission.

TL;DR: In this paper, the authors describe clinical management of acromegaly and assess the efficacy of treatments used in standard clinical practice, and present a study to evaluate the effectiveness of these treatments.

TL;DR: There is relatively little impairment on overall HRQoL and perception of subjective health in patients with NFAs with contemporary treatment and careful attention to replacement regimens, according to a large cross-sectional study published by Capatina et al.

TL;DR: In this paper , the authors evaluated whether age-related differences exist in clinical characteristics, diagnostic approach and management strategies in patients with Cushing's syndrome included in the European Registry on Cushing Syndrome (ERCUSYN).